Physicochemical characterization of solid dispersion systems of tadalafil with poloxamer 407

D. A. Hussar, New drugs of 2003, J. Am. Pharm. Assoc. 44 (2004) 168-206; DOI: 10.1331/154434504773062627.10.1331/154434504773062627Search in Google Scholar

H. Porst, H. Padma-Nathan, F. Giuliano, G. Anglin, L. Varanese and R. Rosen, Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial, Urology 62 (2003) 121-125; DOI: 10.1016/S0090-4295(03)00359-5.10.1016/S0090-4295(03)00359-5Search in Google Scholar

H. Schott, L. C. Kwan and S. Feldman, The role of surfactant in the release of very slightly soluble drugs from tablets, J. Pharm. Sci. 71 (1982) 1038-1045; DOI: 10.1002/jps.2600710921.10.1002/jps.2600710921Search in Google Scholar

F. Veiga, J. J. C. Teixeria-Dias, F. Kedzeierewicz, A. Sousa and P. Maincent, Inclusion complexation of tolbutamide with β-cyclodextrin and hydroxypropyl-β-cyclodextrin, Int. J. Pharm. 129 (1996) 63-71; DOI: 10.1016/0378-5173(95)04243-1.10.1016/0378-5173(95)04243-1Search in Google Scholar

J. O. Henck, U. J. Griesser and A. Burger, Polymorphie von Arzneistoffen eine wirtschaftliche Herausforderung?, Pharm. Ind. 59 (1997) 165-169.Search in Google Scholar

L. Christian and J. Dressman, Improving drug solubility for oral delivery using solid dispersions, Eur. J. Pharm. Biopharm. 50 (2000) 47-60; DOI: 10.1016/S0939-6411(00)00076-X.10.1016/S0939-6411(00)00076-XSearch in Google Scholar

D. Q. M. Craig, The mechanisms of drug release from solid dispersions in water-soluble polymers, Int. J. Pharm. 231 (2002) 131-144; DOI: 10.1016/S0378-5173(01)00891-2.10.1016/S0378-5173(01)00891-2Search in Google Scholar

M. Newa, K. H. Bhandari, D. X. Li, T. H. Kwon, J. A. Kim, B. K. Yoo, J. S. Woo, W. S. Lyoo, C. S. Yong and H. G. Choi, Preparation, characterization and in vivo evaluation of ibuprofen binary solid dispersions with poloxamer 188, Int. J. Pharm. 343 (2007) 228-237; DOI: 10.1016/j.ijpharm.2007.05.031.10.1016/j.ijpharm.2007.05.031Search in Google Scholar

G. Dumortier, J. L. Grossiord, F. Agnely and J. C. Chaumeil, A review of poloxamer 407 pharmaceutical and pharmacological characteristics, Pharm. Res. 23 (2006) 2709-2728; DOI: 10.1007/s11095-006-9104-4.10.1007/s11095-006-9104-4Search in Google Scholar

D. S. Singhare, S. Khan and P. G. Yeole, Poloxamers: Promising block co-polymers in drug delivery, Indian J. Pharm. Sci. 67 (2005) 523-531.Search in Google Scholar

J. L. Ford, The current status of solid dispersions, Pharm. Acta Helv. 61 (1986) 69-88.Search in Google Scholar

J. A. Ryan, Compressed pellet X-ray diffraction monitoring for optimisation of crystallinity in lyophilised solids: imipenem: cilastatin sodium case, J. Pharm. Sci. 75 (1986) 805-807; DOI: 10.1002/jps.2600750817.10.1002/jps.2600750817Search in Google Scholar

Y. J. Park, C. S. Yong, H. M. Kim, J. D. Rhee, Y. K. Oh, C. K. Kim and H. G. Choi, Effect of sodium chloride on the release, absorption and safety of diclofenac sodium delivered by poloxamer gel, Int. J. Pharm. 263 (2003) 105-111; DOI: 10.1016/S0378-5173(03)00362-4.10.1016/S0378-5173(03)00362-4Search in Google Scholar

G. Mooter, P. Augustijns, N. Blaton and R. Kinget, Physico-chemical characterization of solid dispersions of temazepam with polyethylene glycol 6000 and PVP K30, Int. J. Pharm. 164 (1998) 67-80; DOI: 10.1016/S0378-5173(97)00401-8.10.1016/S0378-5173(97)00401-8Search in Google Scholar

T. Save and P. Venkitachalam, Studies on solid dispersions of nifedipine, Drug Dev. Ind. Pharm. 18 (1992) 1663-1679; DOI: 10.3109/03639049209040893.10.3109/03639049209040893Search in Google Scholar